John Ballantyne - Director, 10%+ Owner at Glucotrack, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by John Ballantyne since 21 Oct 2025

Reported holdings for John Ballantyne in Glucotrack, Inc.

Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
2,743,591
Estimated value
$85,051,321
Report date
12 Mar 2025
Price
$31.00
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
4,126
Estimated value
$127,906
Report date
26 Mar 2025
Price
$31.00
Ownership
Direct
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Series A Common Warrant
Shares / value
132,036
Estimated value
Report date
14 Nov 2024
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Warrants to Purchase Common Stock
Shares / value
59,260
Estimated value
Report date
30 Jul 2024
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Series B Common Warrant
Shares / value
0
Estimated value
Report date
12 Mar 2025
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount

Transaction history for John Ballantyne in Glucotrack, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .